FAB-144

FAB-144
Systematic (IUPAC) name
	1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indazole
Clinical data
Legal status	CA: Schedule II;
Chemical data
Formula	C20H27FN2O
Molar mass	330.4 g/mol
	SMILES FCCCCCN1N=C(C(C2C(C)(C)C2(C)C)=O)C3=C1C=CC=C3 ;
	InChI InChI=1S/C20H27FN2O/c1-19(2)18(20(19,3)4)17(24)16-14-10-6-7-11-15(14)23(22-16)13-9-5-8-12-21/h6-7,10-11,18H,5,8-9,12-13H2,1-4H3 ; Key:LVJQJRUAYXVEGN-UHFFFAOYSA-N ;

FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[1] It is the indazole analogue of XLR-11.

Legal status[edit]

Sweden's public health agency suggested classifying FAB-144 as hazardous substance on November 10, 2014.^[2]

^ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.